Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups

Reuters

Sep 08

Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups

Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including Shanghai Industrial Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR Therapeutics and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on September 08, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2565508501"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2565508501\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2565508501?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-08 14:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2565508501","market":"us","top_or_hot":-1,"title":"Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including <a href=\"https://laohu8.com/S/SGHIF\">Shanghai Industrial</a> Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on September 08, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-08 14:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including <a href=\"https://laohu8.com/S/SGHIF\">Shanghai Industrial</a> Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on September 08, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1607","symbol_name":"新IT概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDLcg1Qdl:1","article_id":"2565508501","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2565508501","pubTimestamp":1757311671,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including Shanghai Industrial Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR Therapeutics and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1607":"新IT概念","BK1193":"电脑硬件、储存设备及电脑周边","03396":"联想控股"},"translate_title":"拜耳公司在中国推出拜耳Co.Lab AdVenture，欢迎新的生物技术初创公司，扩大全球创新网络","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03396":0.9},"content_text":"Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups\n    \n\n        Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including Shanghai Industrial Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR Therapeutics and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on September 08, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}